Automated Keratinocyte Preparation for Scalable hPSC Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating human pluripotent stem cells (hPSCs) into keratinocytes are laborious, operator-dependent, and require manual manipulations, leading to variability in cell quality and efficiency, making large-scale production challenging and costly.
Innovation Solution
An automated method involving the formation of aggregates of hPSCs on a protein matrix, followed by sequential culture stages with defined media containing retinoic acid and BMP4, and subsequent treatment with trypsin to obtain a homogeneous population of keratinocytes, all performed without human intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If manual isolation and culture of keratinocytes are performed, then high purity and confluence are achieved, but the process is time-consuming and labor-intensive
Solution Approach 1:
The patent replaces manual mechanical isolation procedures with an automated magnetic bead-based system. Magnetic beads coated with specific antibodies bind to keratinocytes, allowing automated magnetic separation to isolate pure keratinocyte populations without manual intervention, thus maintaining high purity while dramatically reducing isolation time and labor requirements.
Solution Approach 2:
The patent changes the physical state and properties of the isolation medium by using magnetic beads with specific surface coatings. This parameter change enables selective binding to keratinocytes through magnetic properties, allowing automated separation that maintains cellular integrity and purity while reducing processing time compared to traditional manual methods.
2Loss of time
If automated magnetic bead isolation is used, then isolation time is reduced, but cell stress and contamination risk increase
Solution Approach 1:
The patent uses magnetic beads as intermediary carriers that bind to keratinocytes through specific antibody-coatings. These beads act as a gentle mediator that allows automated magnetic separation without direct mechanical stress on the cells. The beads protect cells during automation while enabling rapid isolation, thus reducing cell stress despite the automated process.
Solution Approach 2:
The patent replaces harsh mechanical separation methods with gentle magnetic field-based separation. The magnetic field acts non-invasively on the bead-coated cells, allowing automated isolation without physical stress, shear forces, or contamination risks associated with manual handling, thus maintaining cell health while reducing isolation time.
3Manufacturing precision
If repeated subculturing is performed to achieve confluence, then pure keratinocyte cultures are obtained, but differentiation and senescence occur
Solution Approach 1:
The patent performs preliminary isolation of pure keratinocytes using magnetic bead separation before culture establishment. By obtaining high-purity starter cultures through automated magnetic isolation, the system eliminates the need for repeated subculturing to achieve purity, thus preventing differentiation and senescence while maintaining pure cultures throughout the cultivation period.
Solution Approach 2:
The patent replaces repeated mechanical subculturing with a single automated magnetic isolation step. This substitution achieves culture purity without prolonged culture duration, preventing the cellular stress, differentiation, and senescence that occur during extended subculturing processes.
4Quantity of substance
If primary keratinocytes are cultured for extended periods, then sufficient material is obtained, but cell quality and proliferative capacity decrease
Solution Approach 1:
The patent performs preliminary enrichment of keratinocytes from mixed epithelial samples using magnetic bead isolation. This preliminary action increases the proportion of true keratinocytes in the culture, enabling faster achievement of confluence with higher-quality cells that maintain proliferative capacity, thus obtaining sufficient material without extended culture periods that would degrade cell quality.
Solution Approach 2:
The patent changes the initial cellular composition parameter by selectively enriching keratinocytes through magnetic antibody binding. This parameter change creates cultures with higher keratinocyte density and quality from the start, allowing rapid expansion to sufficient quantities while maintaining cell reliability and preventing senescence.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables large-scale, high-purity production of functional keratinocytes with reduced variability, enhancing scalability and reliability for clinical and research applications.
Implementation Method 1
magnetic beads coated with anti-keratinocyte antibodies were used to isolate keratinocytes from a mixed population of epithelial cells
Implementation Method 2
The automated system performed all mechanical actions including washing, triturating, and resuspending cells
Data Source
Figure 1A~1D
Figure 2A~2B
AI summary
The present invention relates to ex vivo methods for obtaining populations of human keratinocytes derived from human pluripotent stem cells (hPSCs). More particularly, the present invention relates to an automated method that combines in a sequential manner automated differentiation and amplification of a population of hPSC-derived keratinocytes.